Boston, MA, United States of America

Uma Swaminathan

This inventor holds 2 USPTO granted patents. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Uma Swaminathan. Retrieved from https://idiyas.com/inventor/uma-swaminathan-9f5op355

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Uma Swaminathan

Introduction

Uma Swaminathan is an accomplished inventor based in Boston, MA. She has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors targeting specific mutations.

Latest Patents

Uma holds a patent for "Spirocyclic-Substituted 6,7-Dihydro-Pyrano[2,3-d]Pyrimidine Inhibitors of KRAS G12C Mutant." This innovative work showcases her expertise in creating targeted therapies that can potentially improve treatment outcomes for patients with specific genetic mutations.

Career Highlights

Uma is currently employed at Merck Sharp & Dohme LLC, a leading global healthcare company. Her role involves research and development, where she applies her knowledge to advance medical science and create effective treatments.

Collaborations

Uma collaborates with various professionals in her field, including her coworker, Elisabeth Hennessy. Their partnership exemplifies the importance of teamwork in driving innovation and achieving breakthroughs in research.

Conclusion

Uma Swaminathan's contributions to the field of pharmaceuticals through her patent and work at Merck Sharp & Dohme LLC highlight her role as a key innovator in the industry. Her efforts continue to pave the way for advancements in targeted therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…